OBJECTIVE
To assess the potential epidemiological and economic impact of a prophylactic quadrivalent human papillomavirus (HPV) (6/11/16/18) vaccine for preventing cervical cancer, cervical intraepithelial neoplasia grades 2 and 3 (CIN2/3), CIN1 and genital warts.
DESIGN
Cost-utility analysis.
SETTING
UK.
POPULATION
Female and male UK population 12 years or older.
METHODS
We adapted a p...